Gonca Erkose Genc

Dr. Gonca Erkose Genc


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2008 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
Hakan BilhanHakan Bilhan
Hakan Bilhan
TSTonguç Sulun
Tonguç Sulun
GGGonca Erkose Genc
Gonca Erkose Genc
HKHanefi Kurt
Hanefi Kurt
ZEZayre Erturan
Zayre Erturan
TBTayfun Bilgin
Tayfun Bilgin

18 October 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
YBYasemin Bölükbaşı
Yasemin Bölükbaşı
GGGonca Erkose Genc
Gonca Erkose Genc
OOOrhun Orhun
Orhun Orhun
MKMert Ahmet Kuşkucu
Mert Ahmet Kuşkucu
AÇAtahan Çağatay
Atahan Çağatay
ZEZayre Erturan
Zayre Erturan
Candida auris is a species of fungus that has gained importance in recent years owing to its ability to cause hospital infections and epidemics, resistant to antifungal agents and disinfection processes and frequently misidentified by commercial systems. Hospital outbreaks caused by C.auris have been reported from some countries. It has been determined that C.auris has lower virulence than Candida albicans; however, it is associated with high mortality rates in immunocompromised individuals. An increase in the incidence of invasive fungal infections which can lead to serious complications and death, has been identified in severe coronavirus-2019 (COVID-19) patients or immunocompromised individuals with underlying disease. Studies demonstrated an increase in the frequency of C.auris isolation in COVID-19 patients with candidemia. In this report, the first case of COVID-19 positive C.auris fungemia detected in Turkey was presented. A 71-year-old male patient with a history of myocardial infarction, diabetes mellitus, donation of a single kidney and lobectomy surgery due to lung cancer was hospitalized in the pandemic thoracic surgery service due to the findings consistent with viral pneumonia on thoracic computed tomography. Favipiravir 2 x 600 mg and intravenous dexamethasone 1 x 6 mg therapy was administered. The patient tested positive for SARS-CoV-2 polymerase chain reaction, and severe involvement of the left lung was detected in the following days. Antibiotics were administered, followed by insertion of a right jugular vein catheter and initation of tocilizumab. The patient was transferred to the intensive care unit due to increased respiratory distress. Yeast growth was detected in the patient's hemoculture. The yeast strain could not be identified using API ID 32C (bioMerieux, France) (Sacchromyces kluyveri, Candida sake, unacceptable profile), but was identified as C.auris using the VITEK MALDI TOF MS (bioMerieux, France) (99.9%) system and confirmed by sequencing. The minimum inhibitor concentration values were detected as 3 µg/ml for amphotericin B; > 256 µg/ml for fluconazole; 0.19 µg/ml for voriconazole; 0.19 µg/ml for itraconazole; 0.016 µg/ml for posaconazole; 1 µg/ml for caspofungin and 0.094 µg/ml for anidulafungin by using the antibiotic gradient method. The patient's initial treatment comprised meropenem 3 x 1 g, vancomycin 2 x 1 g, caspofungin 1 x 70 mg, and continued as caspofungine 1 x 50 mg after the loading dose, and vancomycin 1 x 1 g/48 hours from the third day of treatment. The patient died on the ninth day after developing candidemia. The present case is the first case of fungemia caused by C.auris in a COVID-19 positive patient in Turkey, and it emphasizes the need of caution for fungemia due to C.auris in intensive care units in our country which has a high COVID-19 incidence.

25 April 2024 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
GGGonca Erkose Genc
Gonca Erkose Genc
İKİlvana Çaklovica Küçükkaya
İlvana Çaklovica Küçükkaya
SKSelda Kömeç
Selda Kömeç
IOIlke Toker Onder
Ilke Toker Onder
OTOyku Toptas
Oyku Toptas
ZEZayre Erturan
Zayre Erturan

13 August 2014 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
DSDilek Satana
Dilek Satana
GGGonca Erkose Genc
Gonca Erkose Genc
ZTZeynep Tamay
Zeynep Tamay
MUMeltem Uzun
Meltem Uzun
NGNermin Guler
Nermin Guler
ZEZayre Erturan
Zayre Erturan
Isolation of mycobacteria in cystic fibrosis (CF) patients is increasingly being reported. Because of having long term antimicrobial treatment, CF patients are at risk of pulmonary infection with especially resistant nontuberculous mycobacteria (NTM) strains. The aim of the present study is to determine the prevalence of mycobacterium spp. and antimicrobial susceptibility in Turkish CF patients.

19 October 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
OOOzlem Oyardi
Ozlem Oyardi
EDElif Sena Demir
Elif Sena Demir
BABusra Alkan
Busra Alkan
SKSelda Komec
Selda Komec
GGGonca Erkose Genc
Gonca Erkose Genc
CGCagla Bozkurt Guzel
Cagla Bozkurt Guzel
Candida auris has emerged as a significant fungal threat due to its rapid worldwide spread since its first appearance, along with its potential for antimicrobial resistance and virulence properties. This study was designed to examine virulence characteristics, the efficacy of ceragenins, and biofilm-derived drug resistance in seven C. auris strains isolated from Turkish intensive care patients. It was observed that none of the tested strains exhibited proteinase or hemolysis activity; however, they demonstrated weak phospholipase and esterase activity. In addition, all strains were identified as having moderate to strong biofilm formation characteristics. Upon determining the minimum inhibitory concentrations (MIC) of ceragenins, it was discovered that CSA-138 exhibited the highest effectiveness with a MIC range of 1–0.5 µg/mL, followed by CSA-131 with a MIC of 1 µg/mL. Also, antimicrobial agents destroyed mature biofilms at high concentrations (40–1280 µg/mL). The investigation revealed that the strains isolated from Türkiye displayed weak exoenzyme activities. Notably, the ceragenins exhibited effectiveness against these strains, suggesting their potential as a viable treatment option.

20 March 2013 in APMIS
Verified
Journal Article
Closed access
PDF file
GGGonca Erkose Genc
Gonca Erkose Genc
ERElvira Richter
Elvira Richter
ZEZayre Erturan
Zayre Erturan